Exact Mass: 587.1280386
Exact Mass Matches: 587.1280386
Found 37 metabolites which its exact mass value is equals to given mass value 587.1280386,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Celecoxib glucuronide
C23H20F3N3O10S (587.0821456000001)
Celecoxib glucuronide is a metabolite of celecoxib and is only found in individuals that have used or taken this drug (PMID: 10681375). Celecoxib (trade name: Celebrex) is a sulfa non-steroidal anti-inflammatory drug (NSAID) and selective COX-2 inhibitor used in the treatment of osteoarthritis, rheumatoid arthritis, acute pain, painful menstruation, and menstrual symptoms, and to reduce numbers of colon and rectum polyps in patients with familial adenomatous polyposis. It is marketed by Pfizer. Celecoxib is available by prescription in capsule form (Wikipedia).
Benzenemethanol, 4-(1-(3,4-bis(difluoromethoxy)phenyl)-2-(3-methyl-1-oxido-4-pyridinyl)ethyl)-alpha,alpha-bis(trifluoromethyl)-
C25H19F10NO4 (587.1154333999999)
(S)-3-(4-(1-(3-(3,5-Dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl)ethyl)benzamido)propanoic acid
Quinoline, 6-(1-methyl-1-(methylsulfonyl)ethyl)-8-(3-((1E)-2-(3-methyl-1,2,4-oxadiazol-5-yl)-2-(4-(methylsulfonyl)phenyl)ethenyl)phenyl)-
C31H29N3O5S2 (587.1548544000001)
((1-(TERT-BUTOXYCARBONYL)PIPERIDIN-4-YL)METHYL)TRIPHENYLPHOSPHONIUM IODIDE
Tradipitant
C28H16ClF6N5O (587.0947507999999)
COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Tradipitant (VLY-686) is a neurokinin-1 (NK-1) antagonist.
MK 0893
6-(1-METHANESULFONYL-1-METHYL-ETHYL)-8-(3-[(E)-2-(4-METHANESULFONYL-PHENYL)-2-(3-METHYL-[1,2,4]OXADIAZOL-5-YL)-VINYL]-PHENYL)-QUINOLINE
C31H29N3O5S2 (587.1548544000001)
Vestipitant Mesylate
C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent
3-(4-(1-(3-(3,5-Dichlorophenyl)-5-(6-methoxynaphthalen-2-YL)-1H-pyrazol-1-YL)ethyl)benzamido)propanoic acid
(Z)-8-(3-(2-(3-methyl-1,2,4-oxadiazol-5-yl)-2-(4-(methylsulfonyl)phenyl)vinyl)phenyl)-6-(2-(methylsulfonyl)propan-2-yl)quinoline
C31H29N3O5S2 (587.1548544000001)
dTDP-4-acetamido-4,6-dideoxy-alpha-D-galactose(2-)
dTDP-3-acetamido-3,6-dideoxy-alpha-D-galactopyranose(2-)
GDP-4-amino-4,6-dideoxy-alpha-D-mannose(1-)
C16H25N6O14P2- (587.0903950000001)
1-[2-[3-Carboxylato-5-[[3-carboxylato-3-(2-carboxylato-2-hydroxy-5-oxopyrrolidin-1-yl)propyl]amino]-3-hydroxy-5-oxopentanoyl]oxyethyl]-2-hydroxy-5-oxopyrrolidine-2-carboxylate
1-[1-carboxylato-3-({(3R)-3-carboxylato-5-[2-(2-carboxylato-2-hydroxy-5-oxopyrrolidin-1-yl)ethoxy]-3-hydroxy-5-oxopentanoyl}amino)propyl]-2-hydroxy-5-oxopyrrolidine-2-carboxylate
Phosphoramidon (Disodium)
C23H32N3Na2O10P (587.1620621999999)
Phosphoramidon Disodium, a microbial metabolite, is a specific metalloprotease thermolysin inhibitor with an IC50 of 0.4 μg/mL. Phosphoramidon Disodium also inhibits endothelin-converting enzyme (ECE), neutral endopeptidase (NEP), and angiotensin-converting enzyme (ACE) with IC50 values of 3.5, 0.034, and 78 μM, respectively[1][2][3].